Toll-like Receptor 4 (TLR4) Antagonist Eritoran Tetrasodium Attenuates Liver Ischemia and Reperfusion Injury through Inhibition of High-Mobility Group Box Protein B1 (HMGB1) Signaling

収録刊行物

  • Molecular Medicine

    Molecular Medicine 20 (1), 639-648, 2014-01

    Springer Science and Business Media LLC

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ